SCHEMBL16692192

SCHEMBL16692192

Cn1c(-c2cccc(-c3cc4ccccc4cc3-c3cccc(-c4nc5ccccc5n4C)c3)c2)nc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
KDM4E B2RXH2 10/20 0.55
ALDH1A1 P00352 10/20 0.55
RAB9A P51151 8/20 0.55
NPC1 O15118 7/20 0.55
TP53 P04637 6/20 0.55
PKM P14618 4/20 0.55
HSD17B10 Q99714 4/20 0.55
GAA P10253 3/20 0.55
ALOX15 P16050 2/20 0.55
MAPT P10636 5/20 0.52
HPGD P15428 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 1/20 0.52
GFER P55789 1/20 0.52
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16692202 0.91 KDM4E (0.59) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL226785 0.91 MEN1 (0.67) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL16692166 0.88 MEN1 (0.54) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL16692210 0.88 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL16692186 0.88 ALDH1A1 (0.67) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL18999305 0.87 MEN1 (0.63) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL16692182 0.86 ALDH1A1 (0.65) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL16692177 0.86 ALDH1A1 (0.65) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL17692188 0.86 MEN1 (0.46) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL29528624 0.86 ALDH1A1 (0.54) MEN1KMT2AKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11362280-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2022-06-14 US disclosed
US-11342508-B2 Organic light-emitting device LG CHEM, LTD. (KR) 2022-05-24 US disclosed
EP-2749560-B1 Novel nitrogen-containing heterocyclic compounds and organic electronic device using same LG CHEMICAL LTD (KR) 2019-10-02 EP disclosed
EP-3434670-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME LG Chem, Ltd. (KR) 2019-01-30 EP disclosed
US-20180175302-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-06-21 US disclosed
US-20180175302-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-06-21 US disclosed
US-9666812-B2 Nitrogen-containing heterocyclic compound and organic electronic device using same LG CHEM, LTD. (KR) 2017-05-30 US disclosed
US-9666812-B2 Nitrogen-containing heterocyclic compound and organic electronic device using same LG CHEM, LTD. (KR) 2017-05-30 US disclosed
US-20150123089-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2015-05-07 US disclosed
US-20150123089-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME LG CHEM, LTD. (KR) 2015-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150123089-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME ODC1, OR10J3, NPM1 MEN1 679/4885KMT2A 558/4885KDM4E 740/4885
US-11342508-B2 Organic light-emitting device CRY1, CRY2, NR2E3 MEN1 2866/4885KMT2A 1753/4885KDM4E 2028/4885
US-20180175302-A1 ORGANIC LIGHT-EMITTING DEVICE CRY1, CRY2, NR2E3 MEN1 2866/4885KMT2A 1753/4885KDM4E 2028/4885
US-11362280-B2 Organic light-emitting device CRY1, CRY2, NR2E3 MEN1 2866/4885KMT2A 1753/4885KDM4E 2028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.